Methods of treatment using 2',3'-dideoxy-2',2'-difluoronucleosid

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514 46, 514 49, 514 50, 514908, 536 2714, 536 282, A61K 3170

Patent

active

055740219

ABSTRACT:
2',3'-Dideoxy-2',2'-difluoronucleosides are useful for treating susceptible neoplasms and viral infections in mammals.

REFERENCES:
patent: 4145531 (1979-03-01), Eckstein et al.
patent: 4321366 (1982-03-01), Bobek et al.
patent: 4526988 (1985-07-01), Hertel
patent: 4681873 (1987-07-01), McNamara et al.
patent: 4692434 (1987-09-01), Hertel
patent: 4808614 (1989-02-01), Hertel et al.
patent: 4880782 (1989-11-01), Eckstein et al.
patent: 4908440 (1990-03-01), Sterzicki et al.
Herdewijn et al., "Synthesis . . . Analysis", J. Med. Chem, vol. 30, pp. 2131-2137 (1987).
Bergstrom et al. "Abstract presented at Spring 1983 ACS Meeting" in Seattle.
Wright and Taylor, Carbohydrate Res. 6, 347-54 (1968).
C. A. Abstract 109:222451f (1989).
The New England Journal of Medicine, vol. 316, No. 9, 26 Feb. 1987, "Development of Antiretroviral Therapy For The Acquired Immunodeficiancy Syndrome and Related Disorders", Yarchoan, et al.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Methods of treatment using 2',3'-dideoxy-2',2'-difluoronucleosid does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods of treatment using 2',3'-dideoxy-2',2'-difluoronucleosid, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of treatment using 2',3'-dideoxy-2',2'-difluoronucleosid will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-562606

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.